Some indices characterizing medical care to children with cancer in the Russian Federation


Cite item

Full Text

Abstract

Introduction. The large size of the Russian Federation, different size and density of the child population in the regions of the country require for careful planning organization of care for children with cancer and the rational use of available resources, since in spite of the significant progress made in pediatric oncology, malignant neoplasms (External testing) are the second most common cause of the death in children. Purpose of the study. Perfection of the organizational-methodological approaches to care for children with cancer in Russia in order to improve the quality and effectiveness of treatment. Material and methods. In a non-randomized non-controlled study there were included reports of regional ministries and departments of health from 83 subjects of the Russian Federation for 2013. Results. The highest incidence rate of malignant tumors (per 100,000 ofpopulation agedfrom 0 to 17 years) was registered in the Lipetsk region - 21.7, the lowest - in the Republic of Tyva - 5.5. The number of patients newly diagnosed in 2013 was the highest in the Central and Volga Federal Districts - 775 and 653, respectively. The smallest - in the Far Eastern Federal District - 138. The number of primary patients referred to the federal clinic, was the largest in the North Caucasus Federal District (North Caucasus Federal District) - 80%, the lowest - in the South - 32.5%, the largest number of doctors who do not have primary specialization in “Children’s oncology”, was registered in the North Caucasus Federal District and the Volga Federal District - 50%, the lowest - Urals - 14.2%. Total in Russia 51 children’s oncological department operate, while the number of beds in which we treat these patients, including beds in non-core branches is 2021. 390 doctors treat children with cancer, out of which 252 (64, 6%) did not have a certificate in pediatric oncology. In 2013, 33 78 children were registered with the External testing, 1705 (50.5%) of them were directed for the management in federal clinics. Conclusion. It is necessary to improve further the existing vertical provision of high-tech medical care for children with cancer, the creation of regional cancer registers, certification of specialists and the quality control of medical care through the implementation of internal and external audit.

About the authors

Maksim Yu. Rykov

N.N. Blokhin Russian Cancer Research Institute; Scientific Center of Children’s Health; I.M. Sechenov First Moscow State Medical University

Email: wordex2006@rambler.ru
MD, PhD, scientific researcher of the Department of head and neck tumors of the Research Institute of Pediatric Oncology and Hematology Moscow, 115478, Russian Federation

N. A Susuleva

N.N. Blokhin Russian Cancer Research Institute; Russian Medical Academy of Postgraduate Education

Moscow, 115478, Russian Federation

V. G Polyakov

N.N. Blokhin Russian Cancer Research Institute; Russian Medical Academy of Postgraduate Education

Moscow, 115478, Russian Federation

References

  1. Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Злокачественные новообразования в России в 2013 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена; 2015.
  2. Алиев М.Д., Поляков В.Г., Менткевич Г.Л., Маякова С.А., ред. Детская онкология. Национальное руководство. М.: Издательская группа РОНЦ; 2012.
  3. Мень Т.Х., Поляков В.Г., Алиев М.Д. Эпидемиология злокачественных новообразований у детей в России. Онкопедиатрия. 2014; 1(1): 7-12.
  4. Поляков В.Г., Байбарина Е.Н., Чумакова О.В., Сусулева Н.А., Рыков М.Ю. Медицинская помощь детям с онкологическими заболеваниями в Российской Федерации. Онкопедиатрия. 2015; 2(3): 177-87.
  5. Рыков М.Ю., Мень Т.Х., Сусулева Н.А., Поляков В.Г. Обеспечение венозного доступа при лечении детей с онкологическими заболеваниями: пятилетний опыт НИИ детской онкологии и гематологии. Онкопедиатрия. 2015; 2(3): 193-204.
  6. Рыков М.Ю., Поляков В.Г. Клинико-экономический анализ использования различных систем венозного доступа при лечении детей с онкологическими заболеваниями. Фармакоэкономика. Современная фармакоэкономика и фармако-эпидемиология. 2015; (2): 11-5.
  7. Ресурсы и деятельность учреждений здравоохранения. В 3-х частях. М.: Минздрав России. 2013.

Copyright (c) 2016 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies